What is it about?
Childhood obesity progresses to metabolic disturbances via low-grade inflammation. Identifying novel molecules that reflect the activity of the immune responses is critical in understanding its underlying pathogenesis. To the best of our knowledge, the influence of these two CHIT1 gene variants on the plasma CHIT1 activity in children with obesity has not been investigated and reported. We hypothesize that plasma CHIT1 activity, as a marker of low-grade systemic inflammation, might be elevated in children with high levels of obesity. The current study.s objectives were to assess in children: (i) The variability of CHIT1 plasma activity by weight status based on BMI-for-age z scores; (ii) The association of dup24 and G102S polymorphism with plasma CHIT1 activity in patients with different levels of obesity by analyzing the observed difference in enzymatic activity between genotype subgroups and the effect of the Bussink et al. [34] correction method; (iii) The contribution of dup24, G102S polymorphism, and BMI-for-age z score to the variation of CHIT1 plasma activity.
Featured Image
Why is it important?
Circulating CHIT1 might be an accurate indicator of inflammation in children with obesity. Its role should be validated in a larger cohort, and the effect of the dup24 and G102S variants on the CHIT1 activity should also be considered.
Perspectives
Read the Original
This page is a summary of: Evaluation of Circulating Chitotriosidase Activity in Children with Obesity, Journal of Clinical Medicine, June 2022, MDPI AG,
DOI: 10.3390/jcm11133634.
You can read the full text:
Contributors
The following have contributed to this page